Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List.

ABSTRACT:

Objectives

Challenges remain in ensuring universal access to affordable essential medicines. We previously estimated the expected generic prices based on cost of production for medicines in solid oral formulations (ie, capsules or tablets) on the WHO Model List of Essential Medicines (EML). The objectives of this analysis were to estimate cost-based prices for injectable medicines on the EML and to compare these to lowest current prices in England, South Africa, and India.

Design

Data on the cost of active pharmaceutical ingredients (APIs) exported from India were extracted from an online database of customs declarations (www.infodriveindia.com). A formula was designed to use API price data to estimate a cost-based price, by adding the costs of converting API to a finished p

SUBMITTER: Gotham D 

PROVIDER: S-EPMC6773329 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature